BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26433072)

  • 1. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
    Lopategi A; López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Titos E; Clària J
    Mol Cell Endocrinol; 2016 Jan; 419():44-59. PubMed ID: 26433072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of adipose tissue inflammation.
    González-Périz A; Clària J
    ScientificWorldJournal; 2010 May; 10():832-56. PubMed ID: 20454765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
    Samad F; Badeanlou L; Shah C; Yang G
    Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-resolving actions of SPM in adipose tissue biology.
    Clària J; López-Vicario C; Rius B; Titos E
    Mol Aspects Med; 2017 Dec; 58():83-92. PubMed ID: 28341541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3-derived mediators counteract obesity-induced adipose tissue inflammation.
    Titos E; Clària J
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():77-84. PubMed ID: 23707933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.
    Flock MR; Rogers CJ; Prabhu KS; Kris-Etherton PM
    Diabetes Metab Res Rev; 2013 Sep; 29(6):431-45. PubMed ID: 23592441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.
    Jung UJ; Choi MS
    Int J Mol Sci; 2014 Apr; 15(4):6184-223. PubMed ID: 24733068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
    Horrillo R; González-Périz A; Martínez-Clemente M; López-Parra M; Ferré N; Titos E; Morán-Salvador E; Deulofeu R; Arroyo V; Clària J
    J Immunol; 2010 Apr; 184(7):3978-87. PubMed ID: 20207999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues.
    Cohen G; Riahi Y; Sasson S
    Arch Physiol Biochem; 2011 Jul; 117(3):131-9. PubMed ID: 21395403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
    Martínez-Fernández L; Laiglesia LM; Huerta AE; Martínez JA; Moreno-Aliaga MJ
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):24-41. PubMed ID: 26219838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in adipose tissue: What's tipping the scale?
    Lambert JM; Anderson AK; Cowart LA
    Adv Biol Regul; 2018 Dec; 70():19-30. PubMed ID: 30473005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of obesity-induced 'metabolic' tissue remodeling.
    Tanaka M; Itoh M; Ogawa Y; Suganami T
    J Diabetes Investig; 2018 Mar; 9(2):256-261. PubMed ID: 29086488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of inflammation in obesity-induced liver disease.
    Rius B; López-Vicario C; González-Périz A; Morán-Salvador E; García-Alonso V; Clária J; Titos E
    Front Immunol; 2012; 3():257. PubMed ID: 22934096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetuin-A: a novel link between obesity and related complications.
    Trepanowski JF; Mey J; Varady KA
    Int J Obes (Lond); 2015 May; 39(5):734-41. PubMed ID: 25468829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
    Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine functions of adipose tissue.
    Waki H; Tontonoz P
    Annu Rev Pathol; 2007; 2():31-56. PubMed ID: 18039092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and immunomodulatory effects of n-3 fatty acids are different in mesenteric and epididymal adipose tissue of diet-induced obese mice.
    Ludwig T; Worsch S; Heikenwalder M; Daniel H; Hauner H; Bader BL
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1140-56. PubMed ID: 23482450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid makeup of the breast adipose tissue is impacted by obesity and mammary cancer in the mouse: Results of a pilot study.
    Margolis M; Perez O; Martinez M; Santander AM; Mendez AJ; Nadji M; Nayer A; Bhattacharya S; Torroella-Kouri M
    Biochimie; 2015 Jan; 108():133-9. PubMed ID: 25450252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.